News Announcement

Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Glenmark Therapeutics Inc. USA launches Olopatadine Hydrochloride Ophthalmic Solution USP 0.1% (OTC)


Other Categories